Home » Authors » James Etheridge

Articles by James Etheridge

Aptanomics, BI Sign Deal In Aptamer Drug Discovery

Aug. 3, 2005

By James Etheridge

Nucleis Planning Branches In Montreal, Atlanta, Singapore

Aug. 3, 2005

By James Etheridge

Aptanomics, BI Sign Deal In Aptamer Drug Discovery

Aug. 3, 2005

By James Etheridge

French Start-Up Nokad Gets Undisclosed First Financing

July 13, 2005

By James Etheridge

French Start-Up Nokad Gets Undisclosed First Financing

July 13, 2005

By James Etheridge

Endotis Pharma Gets EUR4M In Initial Funding Round

June 29, 2005

By James Etheridge

DrugAbuse Sciences Closes Bridge Loan Financing Of EUR5M

June 29, 2005

By James Etheridge

Endotis Pharma Gets EUR4M In Initial Funding Round

June 29, 2005

By James Etheridge

DrugAbuse Sciences Closes Bridge Loan Financing Of EUR5M

June 29, 2005

By James Etheridge

Activists Impeding Progress Of Transgenic Crops In France

June 22, 2005

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...